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Abstract
The repair of DNA double-strand breaks (DSBs) is critical for the maintenance of genomic integrity and viability for all
organisms. Mammals have evolved at least two genetically discrete ways to mediate DNA DSB repair: homologous
recombination (HR) and non-homologous end joining (NHEJ). In mammalian cells, most DSBs are preferentially repaired by
NHEJ. Recent work has demonstrated that NHEJ consists of at least two sub-pathways—the main Ku heterodimer-
dependent or ‘‘classic’’ NHEJ (C-NHEJ) pathway and an ‘‘alternative’’ NHEJ (A-NHEJ) pathway, which usually generates
microhomology-mediated signatures at repair junctions. In our study, recombinant adeno-associated virus knockout vectors
were utilized to construct a series of isogenic human somatic cell lines deficient in the core C-NHEJ factors (Ku, DNA-PKcs,
XLF, and LIGIV), and the resulting cell lines were characterized for their ability to carry out DNA DSB repair. The absence of
DNA-PKcs, XLF, or LIGIV resulted in cell lines that were profoundly impaired in DNA DSB repair activity. Unexpectedly, Ku86-
null cells showed wild-type levels of DNA DSB repair activity that was dominated by microhomology joining events
indicative of A-NHEJ. Importantly, A-NHEJ DNA DSB repair activity could also be efficiently de-repressed in LIGIV-null and
DNA-PKcs-null cells by subsequently reducing the level of Ku70. These studies demonstrate that in human cells C-NHEJ is the
major DNA DSB repair pathway and they show that Ku is the critical C-NHEJ factor that regulates DNA NHEJ DSB pathway
choice.
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Introduction
One of the most harmful lesions a cell can encounter is a DNA
double-strand break (DSB). In all organisms, efficient repair of
these DSBs is critical for the maintenance of genomic integrity and
viability [1]. Unfortunately, DSBs are frequently generated
endogenously during normal cellular processes such as DNA
replication, lymphoid V(D)J or class-switch recombination and are
induced exogenously by the exposure to a variety of genotoxic
agents such as ionizing radiation or chemotherapeutics [2]. Cells
have conspired to meet this demand on their genetic material with
the evolution of two mechanistically distinct pathways to repair
DSBs: homologous recombination (HR), which takes advantage of
either a homologous chromosome or a sister chromatid to join the
broken DNA ends [3] and non-homologous end joining (NHEJ), a
process that directly joins the DSB with little or no sequence
homology between the broken ends [2]. In bacteria and lower
eukaryotes, HR dominates the DNA DSB repair events whereas in
higher eukaryotes, and especially in mammals, NHEJ is the
preferred pathway for DNA DSB repair. NHEJ consists of at least
two genetically and biochemically distinct sub-pathways: a main—
‘‘classic’’—end-joining pathway (C-NHEJ) and one interchange-
ably referred to as microhomology-mediated end joining (MMEJ)
[4], alternative NHEJ (A-NHEJ), or backup NHEJ (B-NHEJ) [5,6]
(hereafter referred to as A-NHEJ). C-NHEJ, while by no means
precise, results in minimal DNA end processing, whereas A-NHEJ
mechanistically results in deletions per force that are often
accompanied by microhomology at the repair junction {[7,8];
reviewed by [6,9]}.
There are at least seven proteins required for C-NHEJ: Ku70,
Ku86, the DNA dependent protein kinase catalytic subunit (DNA-
PKcs), Artemis, X-ray cross complementing 4 (XRCC4), XRCC4-
like factor (XLF) and DNA ligase IV (LIGIV) {reviewed by [10]}.
The basic mechanism of C-NHEJ has been worked out in great
detail. Ku70 and Ku86 form a heterodimer (Ku) that contains an
internal cavity, which Ku uses to bind to and encircle broken DNA
ends [11]. Ku, besides protecting DNA ends from exonucleolytic
attack, also recruits DNA-PKcs, a phosphoinositol-3-like family
serine/threonine protein kinase [12]. Together, Ku70, Ku86 and
DNA-PKcs form the DNA-dependent protein kinase complex
(DNA-PK) and the assembly of this trimeric complex on the ends
of double-stranded DNA activates the kinase activity of DNA-
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nuclease Artemis, which facilitates ‘‘cleaning up’’ of the ends. As
a final step, ligation of the broken ends is catalyzed by the trimeric
LIGIV complex, which consists of the catalytic core, DNA LIGIV,
and its two accessory factors, XLF and XRCC4.
In contrast to C-NHEJ, the mechanism, the regulation and the
factors involved in A-NHEJ remain elusive. Mechanistically, it is
believed that during A-NHEJ both broken ends are resected 59-to-
39 on one strand to generate 39-single-stranded overhangs
containing regions of microhomology (generally a few nucleotides),
which are then used to mediate the repair event. Because of this
reaction pathway, deletion of the sequences between the
microhomologies occurs as does deletion of one of the blocks of
(micro)homology. Moreover, the remaining block of microhomol-
ogy always resides at the precise site of repair and can be used as a
landmark to define such repair events [6,9].
A-NHEJ was not thought to be a very robust nor particularly
important DSB repair pathway because it could usually only be
detected in the absence of C-NHEJ. Indeed, one of the first
descriptions of A-NHEJ came with the observation that the few
NHEJ DSB repair events that could be detected in Ku86-deficient
budding yeast occurred between short direct repeats [7]. Since
then, there have similar reports in fission yeast [13], frogs [14] and
several mammalian systems [15–22] including humans [23]. The
significance of—and parallel interest in—A-NHEJ increased with
the demonstration that A-NHEJ could substitute at reasonable
levels for C-NHEJ during DNA DSB repair events in murine
lymphoid class switch recombination [24,25] and during certain
types of aberrant V(D)J recombination reactions [26,27]. More-
over, A-NHEJ has been implicated in the generation of large
deletions and other genomic rearrangements in murine cells
[28–30]. Similarly, microhomology has been found at the
recombination junctions of radiation-induced genomic rearrange-
ments [31,32] implying that even radiation-induced DSBs can be
repaired by A-NHEJ. Lastly, microhomologies are frequently
detected at breakpoints for chromosomal deletions and transloca-
tions in human cancer cells [33,34]. These observations have
propelled many laboratories to identify the factors required for A-
NHEJ. These studies have implicated poly (ADP-ribose) polymer-
ase-1 (PARP-1), X-ray cross complementing 1 (XRCC1), DNA
ligase III (LIGIII), polynucleotide kinase (PNK), Flap endonucle-
ase 1 (Fen-1) [5,14,35–37] and most recently the Mre11:R-
ad50:Nbs1 (MRN) complex (reviewed by [38]) but it is clear that
additional factors await identification.
One of the most compelling questions in the DSB repair field is
how pathway choice is determined. That is, once a chromosome
breaks, how does the cell determine whether HR, C-NHEJ or A-
NHEJ will mediate its repair? Since each of these repair pathways
generates a discretely distinct product, the answer to this question
is biologically important. Several laboratories have suggested that
the relative abundance of factors, binding affinities for DNA ends,
cell type specificity and/or cell cycle phases may impact upon this
decision {reviewed in [39]}. These issues are complicated even
more in human somatic cells where the impact of loss-of-function
mutations on some of the C-NHEJ genes has distinctly different
phenotypes than are observed in other mammals. In particular,
Ku70 and Ku86 have evolved an essential telomere maintenance
function that does not seem to be evident in any other mammalian
studied to date [40–43]. Interestingly, Ku seems to exert this
function by repressing the HR-mediated disassembly of telomeres
[44] suggesting that pathway choice is critical for naturally
occurring double-stranded DNA ends as well as broken ones.
To begin to experimentally address some of these issues we have
generated a series of human somatic cell lines genetically
engineered using recombinant adeno-associated virus (rAAV)-
mediated gene targeting [45–47] to contain reduced levels of the
C-NHEJ factors Ku70, Ku86, DNA-PKcs, XLF and LIGIV. We
hypothesized that in the presence of reduced or no C-NHEJ
activity the frequency and regulation of A-NHEJ in human cells
could be assessed. To this end we utilized two in vivo plasmid assays
that have been employed to study end joining in mammalian cells
[26,37,48] to demonstrate that null mutations in DNA-PKcs, XLF
or LIGIV resulted in a severe reduction in the frequency of
productive DNA DSB repair. The small number of repair events
that did occur in these null cell lines were hallmarked by the heavy
usage of microhomology. Thus, these studies confirmed that C-
NHEJ is the dominant NHEJ pathway operative inside human
somatic cells and that in its absence small amounts of A-NHEJ can
be detected. Very surprisingly, and in stark contrast to the results
with DNA-PKcs, XLF and LIGIV-null cell lines, DNA DSB repair
activity was actually slightly elevated in Ku86 conditionally-null
cell lines. These repair events appeared, once again, to be heavily
biased towards microhomology-mediated repair. This result
suggested that Ku86 actively suppresses A-NHEJ in human
somatic cells. This hypothesis was confirmed by using molecular
and genetic approaches to reduce the levels of Ku70 in cell lines
that were null for either DNA-PKcs or LIGIV and which resulted
in cell lines that had regained a DNA DSB repair activity that was
mediated by microhomology. Together, these studies demonstrate
that Ku (Ku70 and Ku86) is the critical regulator of pathway
choice in human somatic cells.
Results
Strategy and cell lines
To elucidate the role of C-NHEJ factors in DNA DSB repair,
we made use of an extrachromosomal reporter assay system
{[37,48]; Figure 1}. This assay permits, in addition to the
generation of defined DSBs, a detailed follow up of the repair of
the reporter plasmid. In this assay, end joining is measured by the
reconstitution of green fluorescent protein (GFP) expression [48].
The reporter pEGFP-Pem1-Ad2 consists of the GFP gene
Author Summary
Humans utilize at least two major pathways to repair DNA
double-strand breaks (DSBs): homologous recombination
(HR) and non-homologous end joining (NHEJ), and there
are at least two genetically discrete sub-pathways of NHEJ:
classical-NHEJ (C-NHEJ) and alternative-NHEJ (A-NHEJ).
Since the products generated by each of these three
repair (sub)pathways differ substantially from one another,
it is biologically critical that certain DSBs are repaired by
certain DSB repair pathways. How this pathway choice is
made in human cells was unclear. In this study, knockout
human cell lines that are defective in core C-NHEJ factors
were generated. These cell lines are by-and-large extreme-
ly deficient in DSB repair, proving that C-NHEJ is the major
DSB repair pathway in human cells. Unexpectedly, cell lines
reduced for the C-NHEJ factors Ku70 or Ku86, carried out
proficient DSB repair because of hyperactive A-NHEJ. In
published work we have also demonstrated that Ku
suppresses HR throughout the genome and at telomeres.
Collectively, these data imply that Ku ensures that C-NHEJ
is the major DSB repair pathway by two mechanisms: i)
enabling C-NHEJ and ii) by actively suppressing HR and A-
NHEJ. Thus, Ku is the critical regulator of pathway choice in
human somatic cells.
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from the rat Pem1 gene (Figure 1A). An exon derived from
adenovirus (Ad2) has been introduced into the middle of the intron
and it is flanked on both sides by HindIII and I-SceI restriction
enzyme recognition sequences. In the unmodified configuration,
GFP is not expressed because the Ad2 exon is efficiently
incorporated into the GFP mRNA (Figure 1C). Digestion of the
plasmid either with HindIII or I-SceI at the flanking sites generates
a linear plasmid lacking the adenoviral exon with either
compatible 59-overhanging cohesive ends or incompatible ends,
respectively (Figure 1B). The HindIII sites are arranged such that
cohesive 4-bp overlapping ends are generated, whereas the I-SceI
sites are arranged in an inverted orientation, which demands that
some sort of processing must occur before the ends can be
rejoined. Thus, the impact of loss-of-function NHEJ gene
mutations on these aspects of end joining can be individually
assessed. Un-digested or partially digested plasmids, because of the
retention of the Ad2 exon, generate a product unable to express
GFP. Due to the buffering capacity of the intron, end joining by
the cellular repair apparatus of transfected, linearized plasmid
usually re-constitutes GFP expression, even when extensive
additions or deletions of nucleotides have occurred (Figure 1C).
As a result, a wide spectrum of end joining events can be detected
and quantitated by FACS (fluorescently activated cell sorting). As a
transfection control, cells are always co-transfected with a pCherry
expression plasmid and the data are expressed as the percentage of
cherry-positive cells that are also green-positive. Lastly, pEGFP-
Pem1-Ad2 contains a bacterial origin of replication and an
antibiotic resistance gene permitting the plasmids to be recovered
from human cells and rescued in E. coli. Consequently, the
structure of the repair junctions, which provides mechanistic
insight into the type of repair that was utilized, can be identified by
DNA sequencing.
This assay system was used to interrogate a series of isogenic
human HCT116 cell lines. The derivative cell lines were
engineered using rAAV gene targeting [46,49] to be reduced or
deficient in the expression of most of the C-NHEJ factors, namely:
Ku70 [42,50], Ku86 [40,44], DNA-PKcs [51], XLF (Fattah et al.,
unpublished) or LIGIV (Oh et al., unpublished). HCT116 is a
human adenocarcinoma somatic tissue culture cell line that is
mismatch repair defective [52,53] and it is important to note that
defects in mismatch repair genes have been implicated in affecting
both HR- and NHEJ-mediated DSB repair efficacy {[54,55]
reviewed by [56]}. Moreover, it is also relevant that the cell line
contains reduced levels of Mre11, Rad50 and Nbs1 [57,58], a
trimeric complex of proteins that have documented roles in HR
and which have recently also been implicated in both C- and A-
NHEJ {[59–61]; reviewed in [38]}. Despite these deficiencies,
HCT116 is only slightly reduced for general NHEJ activity [62].
In addition, it is diploid, has a stable karyotype, exhibits normal
DNA damage checkpoints and is wild-type for most of the other
major DNA DSB repair genes [47]. These facts, combined with
the previous extensive use of HCT116 in gene targeting studies
[47] recommended this cell line for these analyses.
LIGIV is the only C-NHEJ gene that is haploinsufficient for
plasmid DNA end joining in vivo
When HindIII- or I-SceI-linearized pEGFP-Pem1-Ad2 plasmid
was introduced into the parental HCT116 cell line, intracellular
circularization allowing GFP expression could easily be detected
and quantitated by flow cytometry (Figure S1). When the same
experiment was carried out with the C-NHEJ heterozygous cell
lines, significant repair activity was always observed (Figure S1).
Averaged over four experiments, the Ku70, Ku86, DNA-PKcs and
XLF heterozygous cell lines showed only a slightly reduced ability
to repair this DSB that was not significantly different from wild-
Figure 1. Reporter substrate for analysis of NHEJ. A cartoon of the reporter construct (pEGFP-Pem1-Ad2). (A) The construct is essentially a GFP
cassette whose expression is driven by CMV promoter and terminated by the SV40 polyA sequence. ‘‘G’’ is separated from ‘‘FP’’ by a 2.4 kb intron
containing an exon (Ad) from adenovirus that is flanked by HindIII and I-SceI restriction sites. Splice donor (SD) and splice acceptor (SA) sites are
shown. (B) Restriction sites used to introduce DSBs. Digestion with HindIII generates compatible cohesive ends. Because I-SceI has a nonpalindromic
18-bp recognition site, cleavage of the two inverted I-SceI sites generates incompatible ends. (C) Due to the presence of the Ad-exon into the middle
of the Pem1 intron, the Ad exon is efficiently spliced into the middle of the GFP ORF, inactivating the GFP activity and thus making the starting
substrate GFP negative. Both sides of the Ad exon have HindIII/I-SceI restriction sites. Cleavage with either of these endonucleases removes the Ad
exon and upon successful intracellular plasmid circularization GFP expression is restored and can be quantitated by flow cytometry.
doi:10.1371/journal.pgen.1000855.g001
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+/2 cell line possessed only
,65% the repair capacity of the parental cell line and was
reproducibly haploinsufficient (Figure S1 and Figure 2). In no case
was a significant difference in repair frequency between the repair
of HindIII- or I-SceI-plasmid observed (Figure 2). While the FACS
analysis (Figure S1 and Figure 2) measured repair frequency, the
repaired plasmids could also be analyzed molecularly. In
particular, the HindIII-cleaved substrate contained 4 bp compat-
ible overhangs that essentially constituted a stretch of micro-
homology (Figure 1B). If these sequences are used to mediate the
repair event, they generate a slightly smaller plasmid that now
contains a single HindIII restriction enzyme recognition site where
formerly there were two. Consequently, the recovered, repaired
HindIII-linearized pEGFP-Pem1-Ad2 plasmids were re-digested
with HindIII before gel electrophoresis and the frequency of
plasmids that had reconstituted a single HindIII site (‘‘perfect
joins’’) was determined. Ku70
+/2, Ku86
+/2 (Table S1), DNA-
PKcs
+/2 (Table S3), XLF
+/2 (Table S5) and LIGIV
+/2 (Table S7)
cells perfectly rejoined an average of ,37% of the substrates,
which was slightly higher than the 23% perfect rejoining observed
in wild-type cells (summarized in Figure S2 and Figure 5B). Thus,
even though the repair activity was not substantially affected by
the loss of one allele of any of the C-NHEJ genes tested, the repair
profiles shifted towards microhomology-mediated joining. In
several instances, perfectly joined plasmids (as assessed by
restriction digest and gel electrophoresis) were sequenced and
without exception the existence of the expected single HindIII site
was confirmed (data not shown). Lastly, plasmids for those HindIII-
linearized plasmids that did not perfectly rejoin and 30 plasmids
for all of the I-SceI-linearized plasmids (which can not perfectly
rejoin) were sequenced. This analysis demonstrated that the size of
the accompanying deletions (Figure S4, S5), the frequency of
microhomology usage, and the frequency of insertions was, with a
few interesting exceptions (see the Discussion), comparable to that
observed in wild-type cells (Tables S2, S4, S6, S8 and Figure S2,
S3). From these experiments, we concluded that the reduction by
one allele of most C-NHEJ factors is generally aphenotypic for
DNA end joining whereas LIGIV is more haploinsufficient,
implying that LIGIV may be a limiting C-NHEJ factor in human
somatic cells. This latter conclusion supports a prediction made
based on the behavior of purified ligases in vitro [63].
The absence of DNA-PKcs, XLF, and LIGIV greatly reduces
DNA repair activity
In rodents, cells deficient in any of the C-NHEJ components are
generally very deficient in joining virtually all types of DSBs [1].
To test whether C-NHEJ-deficient human cells are also impaired
in end joining we repeated the above experiment in DNA-PKcs-,
XLF- and LIGIV-null cell lines. In all three cases, the frequency of
end joining was greatly reduced (Figure 3). On average, DNA-
PKcs- and XLF-null cell lines were diminished by an order-of-
magnitude and showed only about 10% the repair activity
observed in the parental cell line (Figure 2). The LIGIV-null cell
line was always the most profoundly affected cell line and
performed end-joining only a few percent above background.
The fact that XLF-null cells were reproducibly more active than
the LIGIV-null cells is consistent with XLF playing an important,
but not essential, role in DNA DSB ligation. We next attempted—
as a proof-of-principle—to functionally rescue the XLF-null line to
confirm that the loss of end-joining activity was due specifically to
the respective targeted knockout mutations in these cell lines. A
XLF cDNA was stably introduced via retroviral infection into the
XLF-null cell line and a subclone expressing wild-type levels of
XLF protein was isolated (data not shown). This cell line showed
Figure 2. The impact of C-NHEJ mutations on end joining. Four independent experiments comparable to those depicted in Figure S1 and
Figure 4 were performed and the average percent repair relative to wild-type is shown with the standard deviation.
doi:10.1371/journal.pgen.1000855.g002
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directly demonstrating that the absence of XLF was responsible for
the phenotype of the null cells. In conclusion, these experiments
demonstrated that C-NHEJ is the major NHEJ repair pathway in
human somatic cells and in its absence only low (albeit
detectable—see below) levels of end joining can occur.
The absence of Ku changes the repair profile, but not the
repair activity
Primates are unique in that, in contrast to every other species
examined to date, the Ku genes have evolved to become essential
[40,42,44], due to their ability to suppress lethal HR-mediated
telomere recombination [43]. Consequently, human cell lines that
are null for either Ku70 [42] or Ku86 [40] are not viable. We
have, however, constructed a ‘‘conditionally null’’ (Ku86
flox/2) cell
line for Ku86. This cell line has been engineered through rAAV
gene targeting technology to contain only a singly functional
‘‘floxed’’ allele of Ku86 [44]. In the presence of the Cre
recombinase, the floxed allele is excised and the cells become null
for Ku expression. Importantly, the loss of Ku86 is essentially
complete in 3 to 4 days and although the cells will ultimately
succumb, they generally don’t do so for approximately 2 weeks
[44]. Thus, the day 4 to day 14 window was used to assess the
ability of the cells to perform end joining. Consequently, Ku86
flox/2
cells were either infected with a control adenovirus (AdCMV) or an
adenovirus expressing Cre (AdCre). At 4, 5 and 6 days post-
infection, a portion of the cells were processed for Western analysis,
which confirmed that the levels of Ku86 protein were greatly
diminished in the AdCre-treated cells compared to the control
AdCMV-treated cells (Figure 4A). The levels of Ku86 never go to
zero because a minor portion of the cells are either not productively
infected with the adenoviral vector and/or they do not efficiently
undergo Cre-mediated recombination [44]. At 120 hr post
adenovirus infection, the cells were transfected with pEGFP-
Pem1-Ad2 and 24 hr later the cells were analyzed by FACS
analysis. Very unexpectedly, Ku86
flox/2 +AdCre cells performed
end joining at a wild-type frequency (Figure 4B). Indeed, in four
independent experiments the ‘‘Ku86-null’’ cells reproducibly
seemed to have even slightly higher levels of end joining activity
than wild-type cells, regardless of whether HindIII- or I-SceI-
linearized substrates were used (Figure 2).
We were perplexed by this result until we considered the
possibility that although the frequency of end-joining was not
altered in Ku86-null cells the repair profile might be. To
experimentally test this hypothesis, the repaired HindIII-cleaved
pEGFP-Pem1-Ad2 substrate plasmids were recovered from Ku86-
null cells and analyzed by agarose gel electrophoresis following
HindIII re-digestion for perfect rejoining. In the parental and
heterozygous cell lines this type of repair event was observed in
about 30% of the repaired plasmids (asterisked lanes in Figure 5A
and 5B). In striking contrast, ,80% of all the plasmids recovered
from Ku86-null cells had reconstituted a single HindIII site
(Figure 5A and 5B). Thus, while the overall repair frequency in
Ku86-null cells was not significantly different from wild-type cells,
the repair profile was heavily shifted to one that utilized more
microhomology.
Microhomology-mediated end joining also dominates in
the absence of DNA-PKcs, XLF, and LIGIV
Although end joining was greatly reduced in DNA-PKcs-, XLF-
and LIGIV-null cell lines (Figure 3), it was not zero. Given the
Figure 3. The loss of C-NHEJ greatly reduces end joining. The
indicated cell lines were transfected with HindIII- (Top panels) or I-SceI-
(Bottom panels) linearized pEGFP-Pem1-Ad2 plasmid together with a
pCherry plasmid. The cells were analyzed by FACS 24 hr post
transfection. The number of cells that were doubly EGFP (horizontal)
and pCherry (vertical) positive versus the number that were pCherry
positive was determined. For a given experiment the data are shown as
percent repair in the upper right-hand corner of each plot.
doi:10.1371/journal.pgen.1000855.g003
Figure 4. Ku86-null cells show wild-type levels of end joining
activity. (A) Western blot analysis shows that the expression of Cre
(AdCre) in Ku86
flox/2 cells results in the reduction of Ku86 expression.
AdCMV is a negative control adenoviral vector. (B) the indicated cell
lines were transfected with either HindIII- (Top panels) or I-SceI-
(bottom panels) linearized pEGFP-Pem1-Ad2 plasmid. All symbols are as
in Figure 3.
doi:10.1371/journal.pgen.1000855.g004
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residual repair in these other C-NHEJ-null cell lines was also
heavily biased towards microhomology. Indeed, although there
were far fewer repair events in these three cell lines in comparison
to Ku86-null cells, they were nonetheless predominantly (70% to
80%) mediated by microhomology (Figure 5B). Thus, DNA-PKcs-,
XLF- and LIGIV-null cell lines had an identical repair profile to
Ku86-null cells (Figure 5B), but carried out only 1% to 10% as
many repair events as Ku86-null cells.
A-NHEJ is negatively regulated by Ku in human somatic
cells
The above results suggested that Ku normally actively
suppresses A-NHEJ. In Ku’s presence, even when C-NHEJ is
inactivated by mutations in DNA-PKcs, XLF or LIGIV, A-NHEJ
is apparently still strongly suppressed (Figure 3). In contrast, in
Ku’s absence, A-NHEJ is ‘‘unleashed’’ and rescues the repair
activity of the cells (Figure 4). Interestingly, there is precedent for
this model in the literature. Thus, mouse cell lines deficient for
Ku86 repaired I-SceI-induced DSBs with a frequency similar to
that of wild-type cells but with a repair profile that was biased
towards microhomology [17–21,64]. Moreover, the ionizing
radiation sensitivity of LIGIV-deficient chicken DT40 cells can
be rescued by the deletion of Ku70 [65]. Perhaps most
impressively, LIGIV deficiency in the mouse results in embryonic
lethality and this can be rescued by the deletion of Ku86 [66].
Although, repair profiles were not assessed in the latter two studies,
they are consistent with the absence of Ku de-repressing A-NHEJ
to the point where the phenotypes could be rescued.
To investigate if this paradigm could be extended to human
cells we directly tested whether the strong repair defects of DNA-
PKcs- and the very severe defects of LIGIV-null cells could be
rescued by reducing the amount of Ku in these cell lines. A
combination of genetic and molecular approaches was utilized to
achieve a significant knockdown of Ku, a highly abundant protein.
Thus, rAAV gene targeting was first used to functionally inactivate





+/2 cell lines have ,50%
the level of Ku70 protein compared to wild-type cells (Figure 6B;
[42,50]) and this reduction in Ku slightly rescued the repair
deficiencies of either cell line (compare panel 5 with panel 6 and
panel 8 with panel 9 in Figure 6A; Figure 6C). siRNA against
Ku70 was then used to reduce the level of Ku protein to ,5% of
wild-type (+siRNA, Figure 6B). Impressively, DNA-PKcs
2/2 and
LIGIV
2/2 cells showed wild-type and greatly enhanced, respec-
tively, end-joining activity (compare panel 5 with panel 7 and
panel 8 with panel 10 in Figure 6A; Figure 6C), directly
demonstrating that a reduction in Ku can ‘‘reanimate’’ a cell that
appears ‘‘dead’’ for DNA DSB repair. Importantly, the end joining
occurring in these Ku-reduced cell lines was predominately
microhomology mediated (Tables S3, S4, S7, S8). Moreover,
these data provide a plausible molecular mechanistic explanation
for the earlier genetic results obtained in chickens and mice.
Microhomology-mediated A-NHEJ predominates in
C-NHEJ deficient cells
To confirm and extend the above results, we utilized a reporter
assay that is biased towards detecting A-NHEJ events. pDVG94 is
designed such that the relative efficiency of C-NHEJ versus A-
NHEJ events can be assessed [26,67]. When pDVG94 is digested
with AfeI and EcoRV it results in a blunt-ended linear substrate with
a 6-bp repeat at both ends (Figure 7A). C-NHEJ can rejoin these
ends and yield a wide variety of junctions but A-NHEJ almost
exclusively generates a single product in which the 2 repeats have
been reduced to 1, which simultaneously generates a novel BstXI
restriction enzyme recognition site (Figure 7A). Thus, linearized
pDVG94 plasmid was transfected into the mutant cell lines and
48 hr later repaired plasmids were recovered, purified and then
used as substrates for PCR using a 59-radiolabeled PCR primer
(Figure 7B). The relative level of A-NHEJ is subsequently
determined by quantification of the BstXI-digested PCR products
where a 180 bp product represents the repaired plasmid and a
cleaved 120 bp product is diagnostic of microhomology-mediated
end joining (Figure 7B). The parental cell line, Ku86
flox/2 and
Ku86
flox/2 infected with AdCMV cell lines carried out only a few
percent of microhomology-mediated end joining in this assay
(Figure 7C). In contrast, Ku86-null cells showed on average 45%
microhomology use (Figure 7C). Although this assay cannot be
used to determine the absolute frequency of the individual repair
events, it confirmed that in the absence of Ku, microhomology-
mediated events became easily detectable.
This phenotype was even more evident in the DNA-PKcs-
(Figure 7D), XLF- (Figure 7E) and LIGIV- (Figure 7F) null cell lines.
In the absence of one of these three factors, the frequency of
Figure 5. The absence of Ku86 results in predominately
microhomology-based end joining. (A) HindIII-linearized pEGFP-
Pem1-Ad2 plasmids were recovered from either WT HCT116, Ku86
+/2 or
Ku86
2/2 cells, propagated through E. coli and then analyzed for
retention of a single HindIII restriction site (‘‘perfect rejoining’’) by HindIII
restriction enzyme digestion analysis. The asterisks indicate those
plasmids where perfect rejoining occurred. (B) The results of four or
more experiments similar to those depicted in (A) were combined and
summarized. N.B. The re-expression of a WT DNA-PKcs or XLF cDNA
(+cDNA) in their respective null cell lines reduced the frequency of
perfect rejoining back to WT levels, confirming the specificity of the
effect.
doi:10.1371/journal.pgen.1000855.g005
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tantly, the re-introduction of a wild-type DNA-PKcs or XLF cDNA,
intotheir respectivenull cellline, partially and completely, respectively,
reverted the repair events to a C-NHEJ spectrum. Again, the degree of
complementation was directly related to the degree of complementing
protein expression achieved in these cell lines (data not shown).
Figure 6. The reduction of Ku results in elevated levels of end joining in C-NHEJ mutant cell lines. (A) FACS profiles using the pEGFP-
Pem1-Ad2 reporter substrate are shown for the indicated cell lines. The profiles for the Top and Bottom panels were generated using HindIII- and I-
SceI-linearized plasmids, respectively. The percent of the substrate that was repaired is shown in the right-hand corner of each profile. (B) Western
blot analyses demonstrate a reduction in Ku protein levels. Western blots for extracts derived from the indicated cell lines are shown using antibodies
against either Ku86, Ku70 or (as a loading control) tubulin (Tub). Each of the blots was quantitated using a phosphoimager and the level of a
particular Ku subunit relative to the amount expressed in the parental cell line is indicated below each blot. (C) Four independent experiments
comparable to those depicted in (A) were performed and the average percent repair is shown with the standard deviation.
doi:10.1371/journal.pgen.1000855.g006
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PLoS Genetics | www.plosgenetics.org 7 February 2010 | Volume 6 | Issue 2 | e1000855Figure 7. Independent confirmation of microhomology-mediated end joining in C-NHEJ mutant cell lines. (A) Reporter substrate biased
for use by microhomology-directed NHEJ (A-NHEJ). The reporter has been designed such that cleavage with Eco47III and EcoRV results in a blunt-
ended linear substrate with 6-bp direct repeats (boxes) at both ends. C-NHEJ joining will result in the retention of some of both repeats whereas A-
NHEJ should generate a single repeat, which is a substrate for BstXI. This figure is excerpted from Verkaik et al., 2002, Eur. J. Immunol., 32:701. (B) The
experimental scheme for analysis of the plasmids recovered from transfected cells. The plasmids were subjected to PCR using one radiolabeled
(asterisk) primer. The PCR products were then subjected to BstXI restriction enzyme digestion. (C–F) Left Panels: Autoradiograms of representative
microhomology assays using the indicated cell lines. The size of the primary PCR product (180 bp) and the BstXI cleavage product (120 bp) are
indicated. Right Panels: Three independent experiments similar to the ones shown on the left were quantitated with a phosphoimager and averaged.
doi:10.1371/journal.pgen.1000855.g007
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but in the absence of other C-NHEJ factors, that virtually all of the
end joining in human cells is carried out by microhomology-
mediated processes. In contrast, in the presence of the other C-
NHEJ factors, but in the absence of Ku, some, but not all (see the
Discussion), of the end joining occurs using microhomology.
Ku protects DNA ends from degradation
In every metabolic reaction (e.g., DSB repair, V(D)J recombi-
nation, telomere maintenance, etc.) that Ku participates in, and in
every organism that such reactions have been characterized, Ku’s
absence is marked by hyper-resection of the relevant DNA ends
[11]. To determine if this aspect of Ku’s absence is conserved in
human cells extensive sequencing was carried out of pEGFP-
Pem1-Ad2 plasmids recovered from wild type and Ku86-null cells.
A significant increase in deletion size in Ku86-null cells compared
to wild-type cells was observed. In wild-type cells the median
deletion size was 595 bp whereas in Ku86-null cells it was 1158 bp
for HindIII-linearized plasmids (Table S1 and Figure S4). This
same trend was also observed in I-SceI-linearized plasmids as the
median deletion size was 1097 bp in Ku86-null cells in
comparison to 321 bp in wild type cells (Table S2 and Figure
S5). When the same analysis was carried out for DNA-PKcs-null
(Table S3, S4), XLF-null (Table S5, S6) and LIGIV-null (Tables
S7, S8) cell lines less degradation of the DNA ends compared to
wild-type cells was observed (Figure S4, S5). In summary, the
absence of Ku in human somatic cells carried with it a hyper-
resection phenotype that was identical to that observed for Ku-
dependent reactions in all other species.
A-NHEJ in the absence of Ku in rodent cell lines
Given that the hyper-resection phenotype was conserved
between human somatic cells and other mammals, we anticipated
that the repair phenotypes we have described would also be
conserved. To experimentally test this prediction, we utilized two
well-characterized hamster cell lines that are defective in Ku86
expression, XR-V9B [68] and sxi-3 [69]. The ‘‘parental’’ cell line
from which these two mutant lines were isolated, is the hamster
lung cell line, V79-4. Similar to HCT116 cells, the V79-4 cell line
was able to convert about 50% of the pEGFP-Pem1-Ad2
linearized plasmid to circularized product regardless of whether
it had been linearized with HindIII or I-SceI (Figure 8A). Unlike the
human Ku86-null cell line however, the sxi-3 mutant cell line was
significantly reduced in its ability to repair, although the XR-V9B
line had intermediate activity (Figure 8A). These results were very
similar with a published report using another hamster cell line, xrs-
6 and its complemented control, where a 5-fold reduction in repair
frequency was observed for the mutant line [37]. Thus, 3
independent hamster Ku86-null cell lines showed a deficit in their
repair frequency, which was different from what we have observed
in Ku-depleted human somatic cells. To investigate this in more
detail, we recovered 14 originally HindIII-linearized plasmids from
each of these cell lines and several additional control cell lines and
determined the percentage of perfect joins in the products by
attempting to re-cleave them with HindIII. Only a single perfectly
rejoined plasmid (1/14=7%) was recovered from either V79-4
cells or the related ‘‘wild-type’’ Chinese hamster ovary (CHO) line
(Figure 8B), consistent with C-NHEJ being the major repair
pathway in ‘‘normal’’ hamster somatic cell lines as well. In
contrast, both XR-V9B (10/14=71.4%) and the sxi-3 (7/
14=50%) cell lines showed heavy usage of microhomology-
mediated repair events (Figure 8B). Derivative sxi-3 cell lines,
which express either a complementing cDNA (+cDNA#1) or a
cDNA expressed in the anti-sense orientation (+AScDNA) have
been described [70]. These cell lines showed a restoration of C-
NHEJ (3/14=21.4%) and a lack of restoration (6/14=42.9%),
respectively. To corroborate these results, the cell lines were also
subjected to the independent repair assay using the linearized
pDVG94 plasmid. In this instance, both XR-V9B and sxi-3 again
showed a much higher usage of A-NHEJ than the parental V79-4
cell line and this could be rescued in two independent cell lines
containing a complementing cDNA, but could not be rescued in
the cell line containing the cDNA expressed in the anti-sense
orientation (Figure 8C). From these experiments, we conclude that
although the loss-of-function of Ku86 phenotypes in human cells is
Figure 8. Microhomology-mediated end joining in hamster
Ku86-null cell lines. (A) The indicated cell lines were transfected with
HindIII- (Top panels) or I-SceI-(Bottom panels) linearized pEGFP-Pem1-
Ad2 together with a supercoiled pCherry plasmid (to monitor
transfection efficiency). The number in the top right corner corresponds
to the percentage of cells that turned green after 24 hr as a percentage
of the cells productively transfected. +cDNA#1 corresponds to a sxi-3
cell line that has been stably complemented with a Ku86 cDNA. (B)
HindIII-linearized pEGFP-Pem1-Ad2 plasmids were recovered from the
indicated cell lines, propagated through E. coli and then analyzed for
retention of a single HindIII restriction site (‘‘perfect rejoining’’) by HindIII
restriction enzyme digestion analysis. (C) The indicated cell lines were
transfected with the pDVG94 plasmid that had been linearized by
Eco47III and EcoRV digestion. After 24 hr, the plasmids were recovered
and then analyzed by PCR as described in Figure 7.
doi:10.1371/journal.pgen.1000855.g008
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A-NHEJ, the ability to de-repress A-NHEJ—as scored by these
extrachromosomal assays—is not conserved.
Discussion
We have utilized rAAV knockout technology to construct a
powerful reagent: a series of isogenic human cell lines that are
defective for genes required for the C-NHEJ-mediated branch of
DNA DSB repair. We used these cell lines along with several
informative reporter systems to demonstrate that wild-type human
cells vastly prefer to utilize C-NHEJ over A-NHEJ for end joining
reactions. Unexpectedly, the absence of the proximal C-NHEJ
factor Ku, resulted in cells that still carried out robust levels of end
joining, suggesting that Ku normally suppresses other end joining
pathways. This model was supported by the construction of double
mutant cell lines, which demonstrated that the reduction of Ku in
a cell that was incapable of carrying out C-NHEJ still resulted in
high levels of end joining. Thus, these studies demonstrate that Ku
is the critical regulator for determining pathway choice in human
somatic cells.
Ku, the ‘‘mother’’ of all DSB repair inhibitors?
Ku is a heavily researched DNA repair factor and the majority
of studies rightfully concentrate on some aspect of Ku’s ability to
positively facilitate the myriad of repair and recombination
reactions that require C-NHEJ. In this and related studies, we
have recently documented that Ku has an additional and hitherto
underappreciated function—it is a powerful inhibitor for all the
other DNA DSB repair pathways. Specifically, we have demon-
strated that Ku is an essential repressor of HR-mediated aberrant
telomere recombination. In the absence of Ku, the HR apparatus
can apparently gain access to the telomeric ends and generate
lethal telomeric shortening [43,44]. Thus, Ku can inhibit HR
specifically at telomeres. Moreover, in a study that characterized
generalized rAAV-mediated gene targeting—a process that
requires HR—for loci scattered throughout the genome the
absence of Ku resulted in a ,10-fold increase in correct gene
targeting [42]. Importantly, the increase in correct gene targeting
came at no expense to random integrations. These data strongly
suggested that the reduction of Ku in human somatic cells de-
repressed HR enough to facilitate much higher levels of gene
targeting while simultaneously allowing other repair pathways to
carry out random integrations at wild-type levels. This conclusion
is completely supported by the data provided in this present study.
Thus, here we have documented that in the absence of Ku, A-
NHEJ is greatly up-regulated. Together, these and other [5,37]
studies have revealed that Ku can inhibit HR at telomeres, and it
can inhibit HR and A-NHEJ throughout the genome. Moreover,
this work and the work of Fattah et al. [42] make the strong
prediction that the random rAAV integrations observed in Ku-
deficient cells are mediated by A-NHEJ.
Is the inhibitory activity of Ku conserved?
Although we observed the reliance on A-NHEJ in Ku-deficient
hamster cell lines, we did not observe the strong de-repression of
A-NHEJ activity that we had observed for human somatic cells
(Figure 8A). An identical lack of de-repression using the same assay
system was reported in a set of independent hamster Ku86 mutant
cell lines [37] and a similar conclusion had previously been
reached using extracts derived from these hamster mutants in vitro
[16]. However, this de-repression has been observed in rodents by
a number of investigators, predominately in mouse MEF or ES cell
lines [15,19,21,64,71], but also in hamster cell lines [17,18,20].
The difference between these studies is that ours and the ones
where de-repression was not observed were performed using
extrachromosomal reporters and those where de-repression was
observed were performed with chromosomally integrated reporter
constructs. Thus, it appears in mammals as if the presence of Ku is
more critical for chromosomal DSBs (which are of course the most
biologically relevant substrate) and their repair than for extra-
chromosomal DSB repair. The basis for this distinction is not
known, but it is very likely linked to Ku’s ability to affect
chromatin structure and the impact (direct or indirect) that this
may have on repair processes. Consistent with this view, Ku
separation-of-function mutations, which specifically alter Ku’s
heterochromatin activities, have been demonstrated to affect yeast
Ku’s ability to modulate telomere recombination [72]. Together,
these results suggest that the difference between humans and
rodents is not one of kind, but one of degree. Thus, virtually all of
the loss-of-function phenotypes that have been described for
human Ku can be observed in rodent Ku mutant lines, although
the effects are generally—and with profound consequences—
ameliorated.
How does Ku orchestrate all this inhibition?
Many models can be envisioned for how Ku suppresses A-
NHEJ. One possibility is that Ku, via direct protein:protein
interaction, sequesters a key A-NHEJ factor from performing its
function. In a Ku-deficient cell, this factor would be free to
facilitate A-NHEJ. A good candidate for such a putative factor
exists. Thus, a bevy of independent laboratories have demonstrat-
ed that PARP-1 interacts with Ku [73–77]. And a PARP-1
interaction domain has been defined in the Ku70 subunit at
AA243–261 [76]. This model predicts that a cell expressing a
Ku70 incapable of interacting with PARP-1 (e.g., mutated at
residues AA243–261) would phenocopy the Ku loss-of-function
mutations and we are attempting to construct such a cell line. A
second, and in our minds, likelier possibility, is that Ku controls A-
NHEJ by regulating access to the substrate; namely, a dsDNA end.
We prefer this model because not only does Ku repress A-NHEJ
but it also represses HR at internal loci [42] and at telomeres
[43,44,72]. While it is possible that Ku mediates all of this
repression by physically binding to and inhibiting/sequestering a
different protein or proteins for each reaction, it seems simpler if
Ku simultaneously regulates all three processes by regulating
access to the substrate for all of these pathways: double-stranded
DNA ends. Specifically, we propose that in order to be channeled
into a particular pathway (HR, A-NHEJ or C-NHEJ), that
pathway’s DNA binding factor (probably RAD52, PARP-1 and
Ku, respectively) needs to bind onto the ends of the break and
subsequently recruit their pathway’s associated factors. We posit
that Ku generally gets to the ends of a dsDNA break faster and/or
with higher affinity than RAD52 or PARP-1 and once there it
blocks their access, such that repair is fated to occur by C-NHEJ.
This model is by no means novel and has been proposed by several
investigators and was broached at least a decade ago [78],
although it still remains largely untested. In this regard, a cell line
that expressed a double-stranded DNA end binding defective Ku
mutant would be predicted to be incapable of repressing either
HR or A-NHEJ. Lastly, this model, in particular, could explain the
differences between mice and humans. In mice, the levels of Ku/
DNA-PK are much lower than they are in humans and
consequently there might be a ‘‘fair fight’’ between Ku, RAD52
and PARP-1 over who gets to a broken end. In contrast, in human
cells where the levels of Ku/DNA-PK are about 50-fold higher
[11,79], Ku has become the ‘‘bully’’ and essentially dominates
pathway choice.
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In this study we have interrogated our mutant cell lines with two
structurally similar, but fundamentally different, types of DNA
ends. In one of them (HindIII-linearized pEGFP-Pem1-Ad2) a
region of pre-existing microhomology was presented to the cell. In
the other (I-SceI-linearized pEGFP-Pem1-Ad2 and linearized
pDVG94) some processing by the cell was required to reveal the
microhomology. Microhomology-mediated end joining of the
HindIII-linearized pEGFP-Pem1-Ad2 plasmid could be detected in
the wild-type parental cells (Figure 5 and Tables S1, S3, S5, S7).
This perfect end joining increased in Ku heterozygotes and
became the dominant reaction product in Ku- reduced/null cell
lines. These results can be most simply interpreted if Ku inhibits
A-NHEJ and as the level of Ku is reduced the levels of A-NHEJ
reciprocally rise. The data generated using the two repair
substrates that required processing suggests that this model is,
however, over-simplified. Thus, as the level of Ku was reduced in
the various cell lines the frequency of microhomology-mediated
end joining increased with I-SceI-linearized pEGFP-Pem1-Ad2
and linearized pDVG94, but so did other end joining activities.
This was most evident in the experiments using pDVG94 where
,55% of the repaired plasmids in a Ku-null cell did not use
microhomology to repair the plasmid (Figure 7C). Sequencing of
these events and those derived from I-SceI-linearized pEGFP-
Pem1-Ad2 did not reveal any novel repair signatures and most
events looked indistinguishable from typical C-NHEJ products
(Table S2). Together, these studies suggest that there may be at
least one additional NHEJ pathway that is distinguishable from C-
NHEJ and A-NHEJ by its lack of requirement for Ku and its lack
of microhomology use, respectively. Needless to say, these
products could also be accounted for by A-NHEJ if the pathway
does not have an absolute requirement for microhomology. The
construction of humans cell lines that are doubly defective for C-
NHEJ and A-NHEJ should genetically address this issue.
The power of rAAV-mediated human somatic cell
genetics
Advances in the DNA DSB repair field have come predomi-
nately from studies on yeast and genetically modified mice. There
are instances, C-NHEJ foremost among them, however, where the
phenotypes of yeast and mice mutants do not accurately
recapitulate the corresponding phenotypes observed in humans.
Since ultimately we wish to apply what we have learned in model
systems to the study of humans in the clinic, a potentially more
appropriate model system is the use of human somatic cells in
culture. There are, of course, attendant limitations to using human
cells in culture and the requisite caution needs to be taken in
extrapolating cell culture results to patients in the clinic. It is,
however, also reasonable to expect that the physiology of human
cells in culture may reflect more accurately the basic biochemical
process of human patients than, say, rodent cell in vivo might. The
strength of the rodent system stems predominately from the ability
to make targeted alterations of individual genes using the
technology of HR [80]. This technology exists for human somatic
cells as well [46,47,81]. Overall, at least 77 different genes have
been functionally inactivated in a total of 45 different human
somatic cell lines {[47] and unpublished data}. To our knowledge,
however, this is one of the first reports of the systematic
inactivation of a large number of genes involved in a single
pathway. Importantly, we have shown that it is possible to make
simple knockouts, conditional knockouts and double mutant
human somatic cell lines with relative ease. The general utility
of rAAV-mediated gene targeting may thus be of interest for
investigators working on biological problems that cannot be
adequately modeled in, for example, the mouse.
Materials and Methods
Cell culture
The human wild-type HCT116 cell line and its derivatives were
cultured in McCoy’s 5A medium containing 10% fetal bovine
serum, 100 U/ml penicillin, and 100 U/ml streptomycin in a
humidified incubator with 5% CO2 at 37uC. Cell lines derived from
correct gene targeting were propagated under G418 (1 mg/ml)
selection. Cell lines carrying exogenous cDNA expression vectors
(either XLF or DNA-PKcs) were grown in 2 mg/ml of puromycin.
Cell lines
The wild-type human HCT116 cell line was obtained from the






2/2 [51] cell lines have been
described. Derivatives of Ku70
+/2 cells treated with Ku70 RNAi
(SMARTPool oligonucleotides; Dharmacon) or stably expressing
shRNA vectors directed against Ku70 have also been described
[42]. The XLF
+/2 and XLF
2/2 (Fattah et al., manuscript in
preparation) and the LIGIV
+/2 and LIGIV
2/2 (Oh et al.,
manuscript in preparation) cell lines were generated by rAAV gene
targeting. Similarly, compound mutant cell lines (e.g., Ku70
+/2:
LIGIV
2/2) were generated using the rAAV targeting technology
described elsewhere [47].
Treatment of Ku86
flox/2 cells with Cre
To generate Ku86-null cells, the Ku86
flox/2 cells were plated
onto a 6-well plate at a density of 5610
4 cells per well and allowed
to attach for 18 hr. Adenoviral infection was carried out by adding
2 ml of fresh media containing 5610
8 virus particles of either a
control (AdCMV) or experimental (AdCre) adenoviral stock to
each well [44]. After 4 days (96 hr) of incubation the cells were re-
plated into 6-well plates and allowed to incubate for another 24 hr
before the cells were transfected with linearized NHEJ substrates
(see below). Flow cytometry was then carried out after an
additional incubation for 24 hr.
The end-joining assay, transfection, and FACS analyses
The in vivo end-joining reporter plasmid pEGFP-Pem1-Ad2
(Figure 1) has been described [37,48]. Prior to transfection, the
pEGFP-Pem1-Ad2 plasmid was digested with HindIII or I-SceI
(NEB) for 8 to 12 hr to generate different types of DNA ends. A
pCherry plasmid (Clontech) was co-transfected with linearized
pEGFP-Pem1-Ad2 as a control of transfection efficiency. The cell
line under analysis was subcultured a day before transfection and
was ,60 to 70% confluent for transfection. Transfections were
performed using Lipofectamine 2000 (Invitrogen) according to
manufacture’s instructions. Green (EGFP) and red (Cherry)
fluorescence was measured by fluorescence-activated flow cytom-
etry (FACS) 24 hr later [37]. For FACS analysis cells were
harvested, washed in 1X PBS and fixed using 2% paraformalde-
hyde. FACS analysis was performed on a FACSCalibur
instrument (BD Biosciences). For the HCT116 cell line a red-
versus-green standard curve was derived with varying amount of
cherry and green plasmids to avoid measurements near the
plateau region. The values of repaired events are reported as a
ratio of cells that were double positive for red and green
fluorescence over total cells that are only positive for red
fluorescence. This ratio normalizes the repair events to the
transfection controls. The values for all the mutants are reported
as a percent repair of wild-type cells.
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The repaired NHEJ reporter pEGFP-Pem1-Ad2 substrates
were rescued from human cells using a Qiagen mini-preparation
protocol, transformed into E. coli (TOP10) and colonies carrying
the repaired plasmids were selected on LB plates containing
30 mg/ml of kanamycin. The fidelity of NHEJ repair events was
examined by digesting the plasmid DNA from individual colonies
with the restriction enzyme HindIII prior to agarose gel
electrophoresis. Precise junctional information was obtained by
DNA sequencing using a variety of primers (sequences available
upon request) located upstream and downstream of the Ad2 exon
sequence. Those events that had not restored the original
restriction site were always analyzed by sequencing. For I-SceI-
digested substrate, all the repair products were directly sequenced,
as incompatible I-SceI sites should not restore the original
restriction site(s).
Microhomology assay
The microhomology assay was performed as described [26]. In
brief, 2.5 mgo fEcoRV- (NEB) and AfeI- (NEB) digested plasmid
pDVG94 were transfected into cells that were ,60% confluent, in
6 well plates, using Lipofectamine 2000 (Invitrogen) according to
manufacturer’s instruction. The transfection efficiencies of wild-
type HCT116 and the derivative mutant cell lines were
determined using the plasmid pEGFP-Pem1 as described above.
After transfection (48 hr), plasmid DNA was recovered using a
modified Qiagen mini-preparation protocol. Repaired pDVG94
plasmid was PCR amplified using primer FM30 and a 59-
radiolabeled primer DAR5 [26]. The PCR product was digested
with BstXI (NEB). Restriction fragments were separated by
electrophoresis along with undigested PCR product in a 6%
polyacrylamide gel in TBE buffer. The gel was subsequently dried
and exposed to film. The bands representing the undigested
(180 bp) or digested (120 bp) PCR products were quantified using
ImageQuant software.
RNA silencing
All RNA interference reagents were purchased from Dharma-
con, including SmartPool siRNA pools against Ku70. Ku70 or
scrambled control siRNAs (0.5 mM) were combined in a 1:1
fashion with Dharmafect-1 reagent in a total volume of 400 mL.
After a 20 min incubation at room temperature the siRNA
solution was diluted to 2.0 mL with complete growth media and
then added to the target cells. This procedure was repeated at least
one additional time at ,24 hr intervals.
Supporting Information
Figure S1 The indicated cell lines were transfected with HindIII-
(Top panels) or I-SceI- (Bottom panels) linearized pEGFP-Pem1-
Ad2 together with a supercoiled pCherry plasmid (to monitor
transfection efficiency). The number in the top right corner
corresponds to the percentage of cells that turned green after 24 hr
as a percentage of the cells productively transfected.
Found at: doi:10.1371/journal.pgen.1000855.s001 (6.55 MB TIF)
Figure S2 The data presented individually in Tables S1, S3, S5,
and S7 using the HindIII-linearized pEGFP-Pem1-Ad2-lenearized
plasmid was consolidated into 4 categories: perfect joins (dark
rectangles), imperfect joins (light gray rectangles), microhomology
(white rectangles), and insertions (dark gray rectangles) and is
presented as the percentage of total events for each of the indicated
cell lines.
Found at: doi:10.1371/journal.pgen.1000855.s002 (8.38 MB TIF)
Figure S3 The data presented individually in Tables S2, S4, S6,
and S8 using the I-SceI-linearized pEGFP-Pem1-Ad2-lenearized
plasmid was consolidated into 3 categories: imperfect joins (light
gray rectangles), microhomology (white rectangles) and insertions
(dark gray rectangles) and is presented as the percentage of total
events for each of the indicated cell lines. N.B. Perfect joining is not
possible with this substrate.
Found at: doi:10.1371/journal.pgen.1000855.s003 (8.70 MB TIF)
Figure S4 The data presented individually in Tables S1, S3, S5,
and S7 using the HindIII-linearized pEGFP-Pem1-Ad2-lenearized
plasmid was analyzed only for deletions. Each dot represents an
individual data point and some dots overlap. The mean (dark
rectangle) and the median (gray rectangle) are shown for each of
the indicated cell lines.
Found at: doi:10.1371/journal.pgen.1000855.s004 (8.41 MB TIF)
Figure S5 The data presented individually in Tables S2, S4, S6,
and S8 using the I-SceI-linearized pEGFP-Pem1-Ad2-lenearized
plasmid was analyzed only for deletions. Each dot represents an
individual data point and some dots overlap. The mean (dark
rectangle) and the median (gray rectangle) are shown for each of
the indicated cell lines.
Found at: doi:10.1371/journal.pgen.1000855.s005 (8.55 MB TIF)
Table S1 Sequence analysis for HindIII-linearized pEGFP-
Pem1-Ad2 plasmids recovered from Ku-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s006 (10.54 MB
TIF)
Table S2 Sequence analysis for I-SceI-linearized pEGFP-Pem1-
Ad2 plasmids recovered from Ku-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s007 (10.06 MB
TIF)
Table S3 Sequence analysis for HindIII-linearized pEGFP-
Pem1-Ad2 plasmids recovered from DNA-PKCS-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s008 (7.79 MB TIF)
Table S4 Sequence analysis for I-SceI-linearized pEGFP-Pem1-
Ad2 plasmids recovered from DNA-PKCS-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s009 (9.39 MB TIF)
Table S5 Sequence analysis for HindIII-linearized pEGFP-
Pem1-Ad2 plasmids recovered from XLF-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s010 (7.26 MB TIF)
Table S6 Sequence analysis for I-SceI-linearized pEGFP-Pem1-
Ad2 plasmids recovered from XLF-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s011 (8.34 MB TIF)
Table S7 Sequence analysis for HindIII-linearized pEGFP-
Pem1-Ad2 plasmids recovered from LIGIV-deficient cells.
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Table S8 Sequence analysis for I-SceI-linearized pEGFP-Pem1-
Ad2 plasmids recovered from LIGIV-deficient cells.
Found at: doi:10.1371/journal.pgen.1000855.s013 (8.11 MB TIF)
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